The U.S. Food and Drug Administration has declined to approve Corcept Therapeutics' drug for the treatment of a rare hormonal ...

The startup’s filing comes during a broader biotech recovery that’s made some industry watchers optimistic IPOs could rebound ...

Wasatch BioLabs (WBL), a leader in native, long-read sequencing and epigenomic analysis, today announced a co-marketing ...

India had scientific talent and a robust biopharma sector that faced challenges of limited industry–academia collaboration, financing, infrastructure, and high clinical trial costs which constrained ...

In this week’s episode of "The Top Line," we take a deep dive into the top-line performance of the biopharma industry in the third quarter. After a slow start to the year, U.S. drugmakers in ...

Simtra BioPharma Solutions, operating from two state-of-the-art facilities, one in Bloomington, IN, and another in Halle, Germany, is positioning itself at the forefront of sterile injectable ...

This year has brought a range of challenges for biopharma companies and their leaders, including on-and-off tariff threats and President Donald Trump's arm-twisting around overseas drug spending. Now, ...

While the average earnout potential per biopharma deal has declined over the last five years, the mean upfront value has been on the rise since 2017, according to data from SRS Acquiom. The mean ...

A bankruptcy judge dismissed a “manufactured” chapter 11 case aimed at slimming down the property holdings of National Resilience, a business founded during the Covid-19 pandemic to buy and lease ...

Raveena obtained her bachelor's degree in biochemistry from the University of Leeds, UK. She has worked in the biopharma industry for more than 15 years, focusing on dealmaking, partnering and ...

A view of Takeda Pharmaceutical Company in Cambridge. Takeda is the largest biopharma employer in the state. (Spencer Grant/GHI/UCG/Universal Images Group via Getty Images) The state's biopharma ...